Global

‡ In these countries please contact our distributor

OASIS® Matrix Products

About

One matrix for the advanced management of challenging wounds.

OASIS Matrix is a porcine derived, intact, 3-dimensional extracellular matrix that acts as a scaffold to support the body's own healing process by allowing cellular migration, vascular ingrowth and the formation of granulation tissue.

Intended use

OASIS Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, tunneled, undermined wounds, diabetic ulcers, trauma wounds (abrasions, lacerations, second-degree burns, skin tears), draining wounds, and surgical wounds (donor sites/grafts, post-Mohs’ surgery, post-laser surgery, podiatric, wound dehiscence).

This device is not indicated for use in third-degree burns.

Contraindication

This device is derived from a porcine source and should not be used in patients with known sensitivity to porcine material.1

OASIS® Matrix should not be applied until excessive exudate, bleeding, acute swelling, and infection are controlled.

Potential complications

The following complications are possible. If any of these conditions occurs, the device should be removed:

  • infection, 
  • chronic inflammation (initial application of wound dressing may be associated with transient, mild, localized inflammation), 
  • allergic reaction, 
  • excessive redness, 
  • pain, 
  • swelling, or 
  • blistering.

For more prescribing information click here

 

References

1 Brown-Etris, M., Cutshall WD, Hiles, MC. A new biomaterial derived from small intestine submucosa and developed into a wound matrix device. Wounds. 2002; 14(4); 150-166.

 

OASIS is a registered trademark of Cook Biotech, Inc.

OASIS Ultra Tri-Layer Matrix

OASIS Ultra Tri-Layer Matrix is composed of porcine small intestinal submucosa (SIS), a scaffold of extracellular matrix (ECM) that helps support the body's own tissue repair mechanisms by1,2:

  • Offering a strong structure of triple-layer SIS that supports the formation of new granulation tissue1,2
  • Providing increased strength, which allows for easy handling, fixation, and application.
  • Supporting both acute and chronic wounds
    - Can be used in tunneled and/or undermined wounds

Available in a wide range of sizes

OASIS Ultra Tri-Layer Matrix is available for use on a variety of wound types, enabling you to always choose the appropriately sized matrix for wounds in the inpatient setting.

 

References

1 Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol. 2002;13(5):377-383.

2
Data on file. Cook Biotech, Inc.


 

OASIS is a registered trademark of Cook Biotech, Inc.

OASIS Wound Matrix

Sophisticated structure

OASISOASIS Wound Matrix is a naturally derived structure that helps support the body's own wound closure mechanisms

 

 

OASISOASIS Wound Matrix is an intact matrix naturally derived from porcine small intestinal submucosa (SIS), indicated for the management of wounds

  • Long 2-year shelf life makes OASIS Wound Matrix easy to incorporate into your routine
  • No preparation required
  • Room temperature and on-the-shelf storage
  • Convenient for use in a variety of settings, including outpatient and OR

 

OASIS is a registered trademark of Cook Biotech, Inc.

This information is intended for health care professionals only.

*The decision to use Smith & Nephew products should be made by a healthcare professional, in line with applicable local protocols.  Smith & Nephew products should always be used for the indications set out in the applicable instructions for use.

United States healthcare professionals only

Learn more about OASIS Matrix products in the US

More